These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 11719834

  • 1. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M, Juhan-Vague I.
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [Abstract] [Full Text] [Related]

  • 2. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
    Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Hamsten A, Arner P.
    Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
    [Abstract] [Full Text] [Related]

  • 3. Relationship between visceral fat and PAI-1 in overweight men and women before and after weight loss.
    Kockx M, Leenen R, Seidell J, Princen HM, Kooistra T.
    Thromb Haemost; 1999 Nov; 82(5):1490-6. PubMed ID: 10595643
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G, Andersen O, Haugaard SB, Lihn AS, Pedersen SB, Madsbad S, Richelsen B.
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [Abstract] [Full Text] [Related]

  • 5. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):688-94. PubMed ID: 12615670
    [Abstract] [Full Text] [Related]

  • 6. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
    Kolehmainen M, Vidal H, Alhava E, Uusitupa MI.
    Obes Res; 2001 Nov 01; 9(11):706-12. PubMed ID: 11707537
    [Abstract] [Full Text] [Related]

  • 7. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
    He G, Pedersen SB, Bruun JM, Lihn AS, Jensen PF, Richelsen B.
    Horm Metab Res; 2003 Mar 01; 35(3):178-82. PubMed ID: 12734779
    [Abstract] [Full Text] [Related]

  • 8. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.
    Obes Res; 2002 Aug 01; 10(8):717-25. PubMed ID: 12181379
    [Abstract] [Full Text] [Related]

  • 9. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
    Kitagawa N, Yano Y, Gabazza EC, Bruno NE, Araki R, Matsumoto K, Katsuki A, Hori Y, Nakatani K, Taguchi O, Sumida Y, Suzuki K, Adachi Y.
    Diabetes Res Clin Pract; 2006 Aug 01; 73(2):150-7. PubMed ID: 16458385
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery.
    Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Klaus A, Patsch JR, Ebenbichler CF.
    Nutr Metab Cardiovasc Dis; 2012 Apr 01; 22(4):340-6. PubMed ID: 21093232
    [Abstract] [Full Text] [Related]

  • 11. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
    Viljanen AP, Lautamäki R, Järvisalo M, Parkkola R, Huupponen R, Lehtimäki T, Rönnemaa T, Raitakari OT, Iozzo P, Nuutila P.
    Ann Med; 2009 Apr 01; 41(2):152-60. PubMed ID: 18855190
    [Abstract] [Full Text] [Related]

  • 12. Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with loss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity.
    Purnell JQ, Cummings D, Weigle DS.
    Int J Obes (Lond); 2007 Feb 01; 31(2):385-9. PubMed ID: 16819531
    [Abstract] [Full Text] [Related]

  • 13. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
    van Harmelen V, Wahrenberg H, Eriksson P, Arner P.
    Thromb Haemost; 2000 Feb 01; 83(2):304-8. PubMed ID: 10739390
    [Abstract] [Full Text] [Related]

  • 14. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.
    Mertens I, Van der Planken M, Corthouts B, Wauters M, Peiffer F, De Leeuw I, Van Gaal L.
    Horm Metab Res; 2001 Oct 01; 33(10):602-7. PubMed ID: 11607880
    [Abstract] [Full Text] [Related]

  • 15. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T, Yang R, Lyles MF, Gong D, Nicklas BJ.
    Am J Physiol Endocrinol Metab; 2005 Apr 01; 288(4):E741-7. PubMed ID: 15562250
    [Abstract] [Full Text] [Related]

  • 16. Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
    Nordt TK, Bode C, Sobel BE.
    Diabetologia; 2001 Sep 01; 44(9):1121-4. PubMed ID: 11596666
    [Abstract] [Full Text] [Related]

  • 17. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
    Oishi K, Ohkura N, Matsuda J, Ishida N.
    Thromb Haemost; 2007 Oct 01; 98(4):864-70. PubMed ID: 17938813
    [Abstract] [Full Text] [Related]

  • 18. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
    Goral J.
    Ann Acad Med Stetin; 2008 Oct 01; 54(2):14-21. PubMed ID: 19374226
    [Abstract] [Full Text] [Related]

  • 19. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G.
    Eur J Clin Invest; 2011 Jan 01; 41(1):39-44. PubMed ID: 20825466
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May 01; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.